Luc Henry | CEO | Limula
Luc graduated from the University of Oxford with a DPhil in Chemical Biology. He has 10 years of research experience and published over 15 peer-reviewed scientific reports in chemistry, biotechnology and immunology. Prior to founding Limula, he was a strategic advisor to the President of EPFL, Martin Vetterli. At Limula, his role is to build meaningful partnerships to maximise the impact of our technology.
Limula is a life science platform technology company based in Lausanne, Switzerland, dedicated to transforming the manufacturing of Cell & Gene Therapies. Their mission is to accelerate the development and commercialisation of new advanced therapies through an automated, on-demand, and scalable manufacturing solution. Limula’s proprietary platform integrates all functionalities into a single device, empowering therapeutics developers to bring life-saving treatments to patients more efficiently.
Powered by: Hyphen Projects | Connect | Join Global Investor Forum | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
| Register here
|
© Copyright 2023 by Hyphen Projects